News and Press Releases
Johnson & Johnson Receives Positive CHMP Opinion for Yuvanci® (Single Tablet Combination Therapy [STCT] of Macitentan and Tadalafil) for Treatment of Patients with Pulmonary Arterial Hypertension (PAH)
If approved, Yuvanci® would become the only single tablet combination for treatment for patients with PAH Johnson & Johnson’s comprehensive PAH portfolio has the potential to cover all guideline-recommended treatment...
Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: July 26, 2024
Janssen-Cilag Limited 50-100 Holmers Farm Way High Wycombe Buckinghamshire HP12 4EG
Eisai Selects Medidata’s Clinical Data Studio to Enhance and Modernize Clinical Trial Efficiency and Patient Experience
AI-enhanced solution will help Eisai accelerate data review and reconciliation by 80% New York – July 25, 2024 – Medidata, a Dassault Systèmes brand and leading provider of clinical trial...
Category: Clinical Trials, Other, Pharmaceutical
Posted: July 25, 2024
Advarra Brings Together Clinical Trial Patient Recruitment Activities to Centralize Visibility and Accelerate Enrolment
New capability provides sponsors and CROs holistic view of sites’ patient recruitment progress 24 July 2024 -- COLUMBIA, MD – – Advarra, the market leader in regulatory review solutions and...
Category: Clinical Trials, Drug Discovery, Other
Posted: July 24, 2024
Broken String Biosciences appoints Steve Becker as Chief Commercial Officer
Appointment brings extensive experience to lead commercial operations and accelerate growth in key global markets Cambridge, UK, 24 July 2024: Broken String Biosciences (“Broken String”), a genomics company driving development...
Category: BioManufacturing
Posted: July 24, 2024
Unit AB3-04, Level 3 BioData Innovation Centre Wellcome Genome Campus Hinxton Cambridge, CB10 1DR
Cherwell appoints new director of operations following retirement of Martyn Young
Newly appointed Andy Charteris to help company focus on continuous improvement initiatives 18 July 2024 -- Bicester, UK -- Cherwell, cleanroom microbiology solutions expert, is pleased to announce the appointment...
Category: BioManufacturing, Drug Discovery, Other, Pharmaceutical
Posted: July 18, 2024
Launton Business Centre Murdock Rd, Bicester OX26 4XB
Avallano releases ProtocolCopilot: Powering Clinical Research with AI-driven Protocol Assistance
16 July 2024 -- South Carolina, US -- Avallano is launching ProtocolCopilot, an innovative AI-driven clinical research protocol assistant designed to transform the way biopharmaceutical companies and clinical research sites...
Category: Biotechnology, Clinical Trials, Other, Pharmaceutical
Posted: July 16, 2024
Optibrium Appoints James Halle as chief commercial officer
Key appointment brings extensive software commercial experience to drive global growth 16 July 2024 – Cambridge, UK – Optibrium, a leading developer of software and AI solutions for drug discovery...
Category: Drug Discovery
Posted: July 16, 2024
Optibrium Ltd. 7221 Cambridge Research Park, Beach Drive, Cambridge, CB25 9TL, UK
Signant Health Appoints 20-Year Life Sciences Veteran Paul Richmond to executive leadership team as chief commercial officer
15 July 2024 – Pennsylvania, US – Signant Health, the leader in evidence generation for modern clinical trials, announced today the appointment of Paul Richmond as chief commercial officer. A...
Category: Clinical Trials, Other, Pharmaceutical
Posted: July 16, 2024
Mogrify appoints Dr Jonathan Appleby as chief scientific officer
Strategic hire bolsters executive leadership team as company progresses multiple therapeutic programmes toward and into clinical development 15 July 2024 – Cambridge, UK – Mogrify, a regenerative medicine company developing...
Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: July 15, 2024
Clinical Trial Media Has Increased Patient Randomisations Up to 50% Among Participants Enrolled Through Its Human-Tech Recruiting Approach
With 50 new on-staff nurses and its machine learning-powered pre-screening technology driving a 15% increase in qualified clinical trial candidates, the trial recruitment company is complementing tech efficiencies with personalised...
Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: July 11, 2024
Pascal Piedbois MD PhD joins One2Treat as chief medical officer to advance patient-centric innovation in clinical trial design and market access
One2Treat reflects patient priorities in a single multi-facet treatment assessment, reducing trial sample size and accelerating patient access to new treatments. 9 July 2024 -- Brussels, Belgium -- In this...
Category: Biotechnology, Clinical Trials, Other, Pharmaceutical
Posted: July 10, 2024
Spur provides update on FLT201 and planned phase III clinical trial
8 July 2024 -- London, UK -- Syncona Ltd, a leading life science investor focused on creating, building and scaling global leaders in life science, notes that its portfolio company...
Category: Clinical Trials, Other, Pharmaceutical
Posted: July 8, 2024
Phase 2b Influenza Field Study Contract
hVIVO to enrol up to 1,000 healthy volunteers as part of a multicentre field study testing an influenza drug candidate, with hVIVO selected as the sole UK clinical site Largest...
Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: July 2, 2024
Clinigen appoints Fernando Ballester as Chief Financial Officer
2 July 2024 -- London, UK -- Clinigen, the global pharmaceutical services company, today announces the appointment of Fernando Ballester as chief financial officer (CFO), effective 1 August 2024. Fernando,...
Category: Other, Pharmaceutical
Posted: July 2, 2024
1nhaler hires pharma industry leaders for key roles ahead of clinical trials
Edinburgh-based 1nhaler has appointed two experts in inhalation and respiratory medicines to the board as it looks to accelerate the development and market-readiness of its novel single use inhaler device....
Category: Clinical Trials, Other
Posted: July 1, 2024
